Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-002844-25Phase 4Completed
Phase 4 trial of ropivacaine in shoulder pain, sponsored by Palle Toft. Primary endpoint: Acute postoperative shoulder pain within 6 hours. Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-002844-25.